Patents by Inventor Ines Atmosukarto

Ines Atmosukarto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chimeric proteins
    Patent number: 10507236
    Abstract: The present invention is directed generally to chimeric proteins that can facilitate targeting of nanoparticulate carriers to antigen presenting cells, and to nanoparticulate carriers comprising these chimeric proteins. The invention is also directed to methods of internalizing an antigen in an antigen presenting cell, and methods of eliciting an immune response to an antigen in a subject, using the nanoparticulate carriers comprising the chimeric proteins.
    Type: Grant
    Filed: October 9, 2015
    Date of Patent: December 17, 2019
    Assignees: Lipotek Pty Ltd, The Australian National University
    Inventors: Jason David Price, Christopher Parish, Ines Atmosukarto
  • CHIMERIC PROTEINS
    Publication number: 20180185464
    Abstract: The present invention is directed generally to chimeric proteins that can facilitate targeting of nanoparticulate carriers to antigen presenting cells, and to nanoparticulate carriers comprising these chimeric proteins. The invention is also directed to methods of internalising an antigen in an antigen presenting cell, and methods of eliciting an immune response to an antigen in a subject, using the nanoparticulate carriers comprising the chimeric proteins.
    Type: Application
    Filed: October 9, 2015
    Publication date: July 5, 2018
    Inventors: Jason David Price, Christopher Parish, Ines Atmosukarto
  • COMPOSITION FOR TARGETING DENDRITIC CELLS
    Publication number: 20140341971
    Abstract: The present invention relates to a composition for targeting dendritic cells. In particular, the present invention relates to a composition comprising: a) one or more antigens; b) an anti-DC-SIGN immunoglobulin single variable domain; and c) a carrier which carries a) and b). The invention further relates to formulations, compositions and devices comprising such anti-DC-SIGN molecules and their use as a medicament and in the treatment of cancer, suitably melanoma.
    Type: Application
    Filed: June 20, 2014
    Publication date: November 20, 2014
    Applicants: LIPOTEK PTY LTD, DOMANTIS LIMITED
    Inventors: Joseph ALTIN, Ines Atmosukarto, Rudolf Maria De Wildt, Christopher Parish, Jason Price
  • Composition for targeting dendritic cells
    Patent number: 8779107
    Abstract: The present disclosure relates to a composition for targeting dendritic cells. In particular, the present disclosure relates to a composition comprising: a) one or more antigens; b) an anti-DC-SIGN immunoglobulin single variable domain; and c) a carrier which carries a) and b). The disclosure further relates to formulations, compositions and devices comprising such anti-DC-SIGN molecules and their use as a medicament and in the treatment of cancer, suitably melanoma.
    Type: Grant
    Filed: October 19, 2009
    Date of Patent: July 15, 2014
    Assignees: Lipotek Pty Ltd, Domantis Limited
    Inventors: Joseph Altin, Ines Atmosukarto, Rudolf Maria De Wildt, Christopher Parish, Jason Price
  • COMPOSITION FOR TARGETING DENDRITIC CELLS
    Publication number: 20110212168
    Abstract: The present disclosure relates to a composition for targeting dendritic cells. In particular, the present disclosure relates to a composition comprising: a) one or more antigens; b) an anti-DC-SIGN immunoglobulin single variable domain; and c) a carrier which carries a) and b). The disclosure further relates to formulations, compositions and devices comprising such anti-DC-SIGN molecules and their use as a medicament and in the treatment of cancer, suitably melanoma.
    Type: Application
    Filed: October 19, 2009
    Publication date: September 1, 2011
    Inventors: Joseph Altin, Ines Atmosukarto, Rudolf Maria De Wildt, Christopher Parish, Jason Price